News

Back

Bioxodes appoints Marc Dechamps as new CEO

October 18th 2022

BSCB Dev

Bioxodes SA, a company specializing in the development of novel therapies for the prevention and treatment of thrombotic and inflammatory diseases, today announces that it has appointed Marc Dechamps as its new CEO. Company founder, Edmond Godfroid, will take up the post of Chief Operations Officer (COO) alongside his existing responsibilities as Chief Scientific Officer (CSO). 

Read Pdf